Vendor review
Allen Biotechnology Co ABC reviews
Allen Biotechnology Co ABC reviews from 75 independent lab tests (Tirzepatide, Retatrutide and Tesamorelin): grade A, purity and fill accuracy. Is Allen Biotechnology Co ABC legit? See what its vials showed.
What the lab tests show
75 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Aug 6, 2026 | Tirzepatide | 99.9 % | 33.3 mg of 30 mg (11 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 9.04 mg of 10 mg (-10 %) | Pass | View |
| Jul 17, 2026 | TB-500 | 10 mg | Fail | View | |
| Jun 26, 2026 | Retatrutide | 99.7 % | 12.9 mg of 10 mg (29 %) | Pass | View |
| Jun 12, 2026 | Tirzepatide | 99.7 % | 68.7 mg of 60 mg (15 %) | Pass | View |
| Jun 4, 2026 | Tesamorelin | 99.8 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| May 11, 2026 | Tirzepatide | 99.9 % | 71.9 mg of 60 mg (20 %) | Pass | View |
| May 11, 2026 | Tirzepatide | 99.9 % | 74.2 mg of 60 mg (24 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 28.4 mg of 30 mg (-5 %) | Pass | View |
| Apr 23, 2026 | Tirzepatide | 98.5 % | 30.1 mg of 30 mg (0 %) | Pass | View |
| Apr 23, 2026 | Tirzepatide | 99.9 % | 30.3 mg of 30 mg (1 %) | Pass | View |
| Mar 12, 2026 | Tesamorelin | 99.9 % | 8.89 mg of 10 mg (-11 %) | Pass | View |
| Mar 6, 2026 | TB-500 | 97.8 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 53.5 mg of 60 mg (-11 %) | Pass | View |
| Mar 4, 2026 | TB-500 | 99.5 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Mar 4, 2026 | BPC-157 | 98.4 % | 11.9 mg of 10 mg (19 %) | Pass | View |
| Mar 2, 2026 | Tesamorelin | 99.9 % | 9.72 mg of 10 mg (-3 %) | Pass | View |
| Mar 1, 2026 | Tirzepatide | 99.9 % | 35.4 mg of 30 mg (18 %) | Pass | View |
| Mar 1, 2026 | Tesamorelin | 99.9 % | 13.3 mg of 10 mg (33 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 99.9 % | 18.9 mg of 20 mg (-6 %) | Pass | View |
| Feb 26, 2026 | Tirzepatide | 99.9 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Feb 25, 2026 | Tirzepatide | 99.9 % | 39.3 mg of 40 mg (-2 %) | Pass | View |
| Feb 25, 2026 | Tesamorelin | 99.9 % | 11.9 mg of 10 mg (19 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 60 mg | Fail | View | |
| Feb 20, 2026 | PT-141 | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Feb 19, 2026 | Tesamorelin | 99.47 % | 8.65 mg of 10 mg (-14 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.14 % | 31.1 mg of 30 mg (4 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 98.62 % | 32.1 mg of 30 mg (7 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.9 % | 21.3 mg of 20 mg (7 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.9 % | 17.8 mg of 30 mg (-41 %) | Pass | View |
| Feb 16, 2026 | Retatrutide | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Feb 15, 2026 | Tirzepatide | 99.8 % | 22.7 mg of 20 mg (14 %) | Pass | View |
| Feb 11, 2026 | Retatrutide | 99.9 % | 15.8 mg of 15 mg (5 %) | Pass | View |
| Feb 11, 2026 | Tesamorelin | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Feb 4, 2026 | Retatrutide | 99.6 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Feb 4, 2026 | Tirzepatide | 99.7 % | 31.9 mg of 30 mg (6 %) | Pass | View |
| Feb 4, 2026 | Tirzepatide | 99.8 % | 11 mg of 10 mg (10 %) | Pass | View |
| Feb 4, 2026 | Tirzepatide | 99.8 % | 44.2 mg of 20 mg (121 %) | Pass | View |
| Feb 4, 2026 | Tirzepatide | 99.9 % | 60.3 mg of 60 mg (0 %) | Pass | View |
| Feb 4, 2026 | Tesamorelin | 99.6 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Feb 2, 2026 | Tirzepatide | 99.37 % | 11 mg of 10 mg (10 %) | Pass | View |
| Feb 2, 2026 | Tirzepatide | 99.38 % | 22.4 mg of 20 mg (12 %) | Pass | View |
| Feb 2, 2026 | BPC-157 | 98.92 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Feb 2, 2026 | BPC-157 | 99.31 % | 9.95 mg of 10 mg (-1 %) | Pass | View |
| Feb 2, 2026 | PT-141 | 96.48 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jan 22, 2026 | Tirzepatide | 99.8 % | 68.5 mg of 60 mg (14 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.95 % | 22.6 mg of 20 mg (13 %) | Pass | View |
| Jan 9, 2026 | Tirzepatide | 99.95 % | 23.4 mg of 20 mg (17 %) | Pass | View |
| Jan 7, 2026 | Tirzepatide | 99.6 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Jan 7, 2026 | BPC-157 | 95 % | 11.6 mg of 10 mg (16 %) | Pass | View |
| Jan 1, 2026 | PT-141 | 99.6 % | 9.2 mg of 12.96 mg (-29 %) | Pass | View |
| Nov 25, 2025 | Tesamorelin | 64.59 % | 9.15 mg of 10 mg (-9 %) | Pass | View |
| Nov 4, 2025 | Retatrutide | 99.95 % | 32.4 mg of 30 mg (8 %) | Pass | View |
| Nov 4, 2025 | Tirzepatide | 99.95 % | 55.4 mg of 50 mg (11 %) | Pass | View |
| Nov 4, 2025 | Tirzepatide | 99.73 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Oct 30, 2025 | Tirzepatide | 99.5 % | 11.93 mg of 10 mg (19 %) | Pass | View |
| Oct 23, 2025 | Retatrutide | 99.95 % | 9.8 mg of 10 mg (-2 %) | Pass | View |
| Oct 23, 2025 | TB-500 | 91.13 % | 9.97 mg of 10 mg (0 %) | Pass | View |
| Oct 23, 2025 | Tirzepatide | 99.95 % | 7.2 mg of 10 mg (-28 %) | Pass | View |
What Allen Biotechnology Co ABC sells
No current listings on record.
About Allen Biotechnology Co ABC
Discord and telegram vendor